{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:17:24Z","timestamp":1778228244270,"version":"3.51.4"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is no established treatment for the acute exacerbation of trigeminal neuralgia. We aimed to investigate the efficacy and safety of intravenous fosphenytoin for this disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective observational study of data from 41 patients with trigeminal neuralgia who received intravenous fosphenytoin therapy. Fosphenytoin diluted with physiological saline was administered intravenously at a loading dose of 9.8\u201320.7 mg\/kg or at a dose of 7.5\u20139.5 mg\/kg when maintenance therapy was needed. Pain was evaluated using a numerical rating scale (NRS), assessed immediately before administration (baseline) and at 2, 12, and 24 h after administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean (\u00b1 standard deviation) NRS score was 9.85 \u00b1 0.69, 0.49 \u00b1 1.47, 1.60 \u00b1 2.19, and 3.46 \u00b1 3.19 at baseline, 2, 12, and 24 h after administration, respectively (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). Intravenous fosphenytoin therapy was effective for the acute exacerbation of trigeminal neuralgia regardless of whether it was administered during the perioperative period of microvascular decompression (MVD) or the type of drugs used concomitantly. Fosphenytoin was effective when re-administered (<jats:italic>n<\/jats:italic> = 14) or at a maintenance dose (<jats:italic>n<\/jats:italic> = 2). The adverse drug reactions observed were mild dizziness in six patients, abnormal auditory perception and thirst in three patients each, and somnolence, decreased SpO<jats:sub>2<\/jats:sub>, and drug eruption in one patient each, all of which were transient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Intravenous fosphenytoin therapy can immediately eliminate pain during acute exacerbation of trigeminal neuralgia and can be a useful therapeutic drug in emergency response or until elective treatment, such as MVD, is performed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1493274","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:30:30Z","timestamp":1736227830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous fosphenytoin therapy for the rescue of acute trigeminal neuralgia crisis in pre- and post-neurosurgical patients: a retrospective observational study"],"prefix":"10.3389","volume":"15","author":[{"given":"Shusaku","family":"Noro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunsho","family":"Asayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1016\/j.bja.2019.05.026","article-title":"A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia","volume":"123","author":"Moore","year":"2019","journal-title":"Br J Anaesth."},{"key":"B2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ene.13950","article-title":"European Academy of Neurology guideline on trigeminal neuralgia","volume":"26","author":"Bendtsen","year":"2019","journal-title":"Eur J Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"3rd","year":"2018","journal-title":"Cephalalgia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S1474-4422(20)30233-7","article-title":"Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia","volume":"19","author":"Bendtsen","year":"2020","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1212\/WNL.0000000000002840","article-title":"Trigeminal neuralgia: new classification and diagnostic grading for practice and research","volume":"87","author":"Cruccu","year":"2016","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/j.pain.0000000000001435","article-title":"The IASP classification of chronic pain for ICD-11: chronic secondary headache or orofacial pain","volume":"160","author":"Benoliel","year":"2019","journal-title":"Pain."},{"key":"B7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","article-title":"Pathophysiology of trigeminal neuralgia: the ignition hypothesis","volume":"18","author":"Devor","year":"2002","journal-title":"Clin J Pain."},{"key":"B9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0885-3924(01)00269-X","article-title":"Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis","volume":"21","author":"Cheshire","year":"2001","journal-title":"J Pain Symptom Manage."},{"key":"B10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1756285615583202","article-title":"Intravenous fosphenytoin for acute exacerbation of trigeminal neuralgia: case report and literature review","volume":"8","author":"Vargas","year":"2015","journal-title":"Ther Adv Neurol Disord."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.92.15_supplement.P5.10-0","article-title":"Intravenous fosphenytoin as a rescue treatment in trigeminal neuralgia crisis","author":"Schnell","year":"2019","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jocn.2021.09.040","article-title":"Intravenous fosphenytoin therapy for rescue of acute trigeminal neuralgia crisis in patients awaiting neurosurgical procedures: a cross-sectional study","volume":"94","author":"Noro","year":"2021","journal-title":"J Clin Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3949\/ccjm.90a.22052","article-title":"Guidelines for the management of trigeminal neuralgia","volume":"90","author":"Chong","year":"2023","journal-title":"Cleve Clin J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1177\/03331024221094536","article-title":"Intravenous fosphenytoin as treatment for acute exacerbation of trigeminal neuralgia: a prospective systematic study of 15 patients","volume":"42","author":"Andersen","year":"2022","journal-title":"Cephalalgia."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/head.13963","article-title":"Trigeminal neuralgia crisis \u2013 intravenous phenytoin as acute rescue treatment","volume":"60","author":"Schnell","year":"2020","journal-title":"Headache."},{"key":"B16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1540-8159.1991.tb04057.x","article-title":"Cerebral haemodynamics during spinal cord stimulation","volume":"14","author":"Meglio","year":"1991","journal-title":"Pacing and Clin Electrophysiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000329357","article-title":"Spinal cord stimulation and cerebrale haemodynamics: updated mechanism and therapeutic impication.s","volume":"89","author":"Visocchi","year":"2011","journal-title":"Stereotact Funct Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/01.STR.11.4.377","article-title":"Cerebral protective, metabolic, and vascular effects of phenytoin","volume":"11","author":"Artru A","year":"1980","journal-title":"Stereotact Funct Neurosurg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000099687","article-title":"Cerebral blood flow velocities and trigeminal ganglion stimulation. A transcranial Doppler study","volume":"66","author":"Visocchi","year":"1996","journal-title":"Stereotact Funct Neurosurg."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1493274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T05:30:32Z","timestamp":1736227832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1493274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":19,"alternative-id":["10.3389\/fneur.2024.1493274"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1493274","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"article-number":"1493274"}}